Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Sir Andrew Witty, a Director, and his Connected Persons, in the Ordinary Shares of GlaxoSmithKline plc (the "Company"):
(a) The transfer on 1 May 2014 by way of gift of 500 Ordinary Shares in the Company from Sir Andrew to each of his two children;
(b) The sale on 1 May 2014 of 731 Ordinary Shares and the repurchase of 724 Ordinary Shares and transfer into an ISA at a price of 1629.0550p and 1629.4650p per share respectively; and
(c) The exercise of options over 100,000 Ordinary Shares on 1 May 2014, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of £11.23 per share, and the sale of 100,000 Ordinary shares at a price of £16.385 per share on 1 May 2014.
The Company was advised of transaction (a) on 1 May and advised of transactions (b) and (c) on 2 May 2014.
This notification relates to transactions notified in accordance with paragraph 3.1.4R(1)(a) and(c) of the Disclosure and Transparency Rules.
V A Whyte
Company Secretary
2 May 2014